Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial.

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. Blood. 2020 06 18; 135(25):2224-2234.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Cyclophosphamide
Etoposide
Female
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse
Male
Middle Aged
Positron-Emission Tomography
Prednisone
Prognosis
Proportional Hazards Models
Prospective Studies
Radiopharmaceuticals
Rituximab
Vincristine
Young Adult

authors with profiles

Mei-Yin Polley